SLIT2 and bladder transitional cell carcinoma: Zhu et al. reported that SLIT2 promoter hypermethylation in bladder urothelial carcinoma and its expression in bladder urothelial carcinoma were lower than those in adjacent samples, which is contrary to the results of our study [34].